Martin Hudec | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Martin Hudec | Medicine | Best Researcher Award

Dr. Martin Hudec, Middle-Slovak Institute of Cardiovascular Diseases (SUSCCH), Slovakia

Dr. Martin Hudec is a distinguished Interventional Cardiologist with extensive experience in cardiovascular diseases. He serves as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases, Slovakia. Holding multiple prestigious qualifications, including MUDr., PhD., MBA, MRCPI, and FESC, he specializes in percutaneous myocardial revascularization and advanced cardiac interventions. His research focuses on improving treatment outcomes for chronic heart failure patients. Over the years, Dr. Hudec has contributed significantly to Slovak and European cardiology through leadership roles, including as a board member of the Slovak Society of Cardiology. An active researcher and educator, he serves as an External Cardiology Tutor at the Slovak Medical University. Recognized internationally, he is a Fellow of the European Society of Cardiology (FESC) and a Member of the Editorial Board of SEEJCA. His commitment to excellence in interventional cardiology continues to shape the field.

Professional Profile

Scopus

Orcid

Research for Best Researcher Award – Martin Hudec

Dr. Martin Hudec is highly deserving of the Research for Best Researcher Award due to his extensive academic background, notable clinical experience, and impactful contributions to the field of cardiology. As a highly qualified specialist in Interventional Cardiology, Dr. Hudec has demonstrated an exceptional commitment to both patient care and research. His qualifications include a Doctor of Medicine (MUDr.), PhD, MBA, and various prestigious certifications, including the MRCPI (Royal College of Physicians of Ireland) and FESC (Fellow of the European Society of Cardiology). His research has significantly advanced the understanding of myocardial revascularization, especially its impact on chronic heart failure, as demonstrated in his PhD dissertation at Comenius University.

Throughout his career, Dr. Hudec has held influential roles in numerous cardiology societies, including serving as a board member for the Slovak Society of Cardiology and the Slovak Resuscitation Society. His contributions to education and knowledge dissemination are equally remarkable, as he serves as an external cardiology tutor at the Slovak Medical University and is a member of the editorial board for the South East European Journal of Cardiology. These roles underscore his leadership in shaping the next generation of cardiologists and his commitment to advancing the field.

🎓 Education

Dr. Martin Hudec’s medical journey began at the Jessenius Faculty of Medicine, Comenius University, Slovakia, where he graduated with distinction in 2004. He completed his General Professional Training (GPT) in 2006 and earned Membership of the Royal College of Physicians of Ireland (MRCPI) in 2008. Pursuing excellence, he completed his Specialty Certificate in Cardiology (CCT) in 2011 and later defended his PhD dissertation on percutaneous myocardial revascularization and chronic heart failure in 2018. His academic contributions are further recognized through leadership roles, including Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee. As an educator, he plays a vital role as a Cardiology Tutor at Slovak Medical University. His academic journey reflects a deep commitment to advancing cardiovascular medicine through education, research, and clinical expertise, shaping the next generation of cardiologists.

💼 Professional Experience 

Dr. Martin Hudec has a stellar career in interventional cardiology, marked by leadership and clinical excellence. Since 2014, he has served as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases. He previously held the role of Head of the Coronary Care Unit (2012-2014) and worked as a Consultant Interventional Cardiologist (2011-present). His expertise was further honed during a Fellowship in Interventional Cardiology at Cork University Hospitals, Ireland (2007-2009), before returning to Slovakia as a Specialist Registrar (2009-2011). Dr. Hudec is an External Cardiology Tutor at Slovak Medical University, actively contributing to medical education. His leadership extends to serving on the board of Slovak and European cardiology committees, ensuring the advancement of interventional techniques and patient care. His dedication has positioned him as a key figure in Slovak cardiovascular medicine.

🏅 Awards and Recognition 

Dr. Martin Hudec is a Fellow of the European Society of Cardiology (FESC), a prestigious recognition of his contributions to cardiovascular medicine. He is a Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee, reflecting his leadership in the field. His research excellence was acknowledged with a PhD award for his dissertation on myocardial revascularization in 2018. In 2021, he was appointed as a Member of the Editorial Board of the South East European Journal of Cardiology (SEEJCA). Additionally, he played a pivotal role in Slovak Resuscitation Society and ESC eLearning Platform. His consistent efforts in cardiology research and patient care have earned him widespread respect among peers and international recognition. As an advocate for innovation in cardiovascular treatment, Dr. Hudec continues to shape the future of interventional cardiology through education, research, and practice.

🌍 Research Skills On Medicine

Dr. Martin Hudec specializes in interventional cardiology, focusing on percutaneous myocardial revascularization and chronic heart failure treatment. His research integrates advanced cardiovascular imaging, catheter-based interventions, and hemodynamic analysis to improve patient outcomes. He has contributed to evidence-based clinical guidelines, enhancing treatment strategies for acute coronary syndrome and structural heart diseases. His expertise in endovascular techniques and stent technologies has positioned him at the forefront of modern cardiology. As a board member of cardiology committees, he actively participates in international research collaborations. His research extends to resuscitation science, electrophysiology, and cardiovascular risk assessment, aiming to reduce mortality rates in cardiac patients. Dr. Hudec’s work is frequently published in peer-reviewed medical journals, and he plays a crucial role in mentoring young cardiologists. His ability to merge clinical practice with innovative research has made him a leading authority in interventional cardiology.

📖 Publication Top Notes

  • Title: Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis
    Authors: Niels van Royen, Ignacio J. Amat, Martin Hudec, Patrick W. Serruys, Andreas Baumbach, et al.
    Journal: EuroIntervention
    Year: 2025
    Citations: 2

  • Title: LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
    Authors: Andreas Baumbach, Niels van Royen, Ignacio J. Amat, Ferencz Arnold-Béla, Orsolya Demeterné Kiss, et al.
    Journal: The Lancet
    Year: 2024
    Citations: 16

  • Title: Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry
    Authors: Martin Hudec, Andrej Kupec, Pavol Gazdic, et al.
    Journal: Anatolian Journal of Cardiology
    Year: 2024

 

Apoorva Ramaswamy | Medicine | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Apoorva Ramaswamy | Medicine | Best Researcher Award

 👤Assist. Prof. Dr. Apoorva Ramaswamy, The Ohio State University Wexner Medical Center, United States

Dr. Apoorva Tewari Ramaswamy is an Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Ohio State University Wexner Medical Center. With a distinguished academic and clinical career, she has contributed significantly to the fields of laryngology and dysphagia. She earned her medical degree from Yale School of Medicine, where she was honored with the prestigious Samuel Jordan Graham Scholarship. Dr. Ramaswamy is dedicated to advancing patient care, research, and education. She has an active role in the Dysphagia Research Society and serves on multiple committees, focusing on diversity, equity, and inclusion (DEI). Her career is marked by academic excellence, innovative research, and an enduring commitment to improving patient outcomes.

Professional Profile

Scopus

Orcid

🌟  Summary of Suitability for the “Research for Best Researcher Award”

Apoorva Tewari Ramaswamy, MD, is exceptionally well-suited for the “Research for Best Researcher Award” due to her extensive educational background, significant research contributions, leadership in her field, and dedication to advancing medical science. She completed her MD from Yale School of Medicine, where she was awarded the Samuel Jordan Graham Scholarship for demonstrating exceptional academic promise in surgery. Additionally, her recognition as Yale College’s Commencement Flag Bearer highlights her extraordinary contributions not only in academia but also within her community.

Dr. Ramaswamy’s research in the fields of laryngology, dysphagia, and esophagology has been widely recognized. She has published influential work, including studies that explore the role of local IgE in eosinophilic esophagitis, which earned her the AAOA Research Prize. Her research contributions continue through her leadership role in various committees and advisory boards, such as the Dysphagia Research Society and the American Broncho-Esophagological Association.

🎓 Education

Dr. Ramaswamy completed her Doctor of Medicine (MD) at Yale School of Medicine (2011–2015), where she was awarded the Samuel Jordan Graham Scholarship for her final year. She also holds a Bachelor of Science in Molecular, Developmental, and Cellular Biology from Yale College (2007-2011), where she was recognized as the Commencement Flag Bearer for her extraordinary contributions. Early in her education, Dr. Ramaswamy earned the “Triple C” award from the Attorney General of New York State, showcasing her excellence in academics and extracurricular leadership during high school. She also demonstrated athletic prowess, earning Volleyball All League honors and the Sirena Wu Dunn Award. Throughout her education, Dr. Ramaswamy’s academic achievements have consistently set her apart as a leader and innovator.

💼 Professional Experience

Dr. Ramaswamy is currently an Assistant Professor at Ohio State University Wexner Medical Center in the Department of Otolaryngology-Head and Neck Surgery. She completed a fellowship in Laryngology and Bronchoesophagology at UC Davis (2020-2021) and residency in Otolaryngology at New York Presbyterian Hospital (2015-2020), where she received several prestigious awards, including the AAOA Research Prize and the Distinguished House Staff Award. Dr. Ramaswamy also has experience working internationally, with a 2009 internship at PEPFAR-Nigeria and research at Yale on vascular surgery. She has served as a faculty member, mentor, and leader in various medical and academic committees, including the Dysphagia Research Society and the American Broncho-Esophagolical Association, advancing research and educational initiatives in her field.

🏅 Awards and Recognition

Dr. Ramaswamy’s career has been marked by several notable accolades. She was honored with the prestigious James Physician Patient Champion Award in 2024. Throughout her residency, she received multiple awards, such as the AAOA Research Prize and In-Service Prize for her academic excellence. As a faculty member, she has received recognition from various professional societies, including the American Head & Neck Society and the Dysphagia Research Society, where she holds leadership positions. Her achievements in academic surgery were further acknowledged with the Distinguished House Staff Award from Weill Cornell Medical Center in 2019, signifying her contributions to patient care, education, and research.

🌍 Research Skills On Medicine

Dr. Ramaswamy’s research is centered around the treatment of dysphagia, laryngology, and the impacts of esophagology on patients with head and neck cancer. Her research contributions have been presented at prestigious international conferences, with a focus on the intersection of voice and swallowing disorders. Dr. Ramaswamy has also conducted studies on local IgE in eosinophilic esophagitis, which won second place at the 2018 AAOA meeting. As a leader in the Dysphagia Research Society and various academic committees, she has promoted diversity and inclusion within the research community. Her work continues to advance understanding of swallowing disorders and provides practical solutions for patient care.

📖 Publication Top Notes

  1. The efficacy of two commercially available devices for airway foreign body relief: A cadaver study

    • Authors: Ramaswamy, A.; Done, A.; Solis, R.; Srikanth, M.; Olinde, L.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1057

  2. Tongue base augmentation to improve swallow function in a cadaveric model

    • Authors: Ramaswamy, A.T.; Cates, D.; Evangelista, L.; Srikanth, M.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1041

  3. The upper esophageal sphincter: anatomy and physiology

    • Authors: Ramaswamy, A.T.; Martell, P.; Azevedo, R.; Belafsky, P.
    • Citation: Annals of Esophagus, 2022
    • DOI: 10.21037/aoe-21-34

  4. Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry.

  5. Office-Based Procedure Training in Laryngology Fellowship Programs.

    • Authors: Enver N.; Ramaswamy A.; Sulica L.; Pitman MJ
    • Citation: The Laryngoscope, 2020-10
    • DOI: 10.1002/lary.29170
    • PMID: 33043999

  6. How I Do It: A Novel Technique for Endoscopic Placement of Stent in Management of Anterior Glottic Webs.

    • Authors: Enver N.; Ramaswamy A.; Pitman MJ
    • Citation: The Laryngoscope, 2020-09
    • DOI: 10.1002/lary.28965
    • PMID: 32902885

  7. Percutaneous and Open Tracheostomy in Patients with COVID-19: Comparison and Outcomes of an Institutional Series in New York City.

    • Authors: Long SM; Chern A; Feit NZ; Chung S; Ramaswamy AT; Li C; Cooley V; Hill S; Rajwani K; Villena-Vargas J, et al.
    • Citation: Annals of Surgery, 2020-09
    • DOI: 10.1097/sla.0000000000004428
    • PMID: 32889885

  8. Common Otologic Surgical Procedures: Clinical Decision-Making Pearls and the Role of Imaging

    • Authors: Peng, T.; Ramaswamy, A.T.; Kim, A.H.
    • Citation: Neuroimaging Clinics of North America, 2019
    • DOI: 10.1016/j.nic.2018.09.008

  9. Management of Vestibular Schwannomas for the Radiologist

  10. Carcinoma presenting as idiopathic anterior glottic webs: A case series

    • Authors: Ramaswamy, A.T.; Tian, L.; Bock, J.M.; Klein, A.M.; Pitman, M.J.
    • Citation: The Laryngoscope, 2019-09
    • DOI: 10.1002/lary.27711

Wentao Han | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han, Department of Ophthalmology, The Second Xiangya Hospital, Central South University, China

Wentao Han is a dedicated ophthalmology researcher specializing in diabetic eye complications, dry eye syndrome, and gene therapy. Currently pursuing his research at the Second Xiangya Hospital of Central South University, China, he has demonstrated a strong passion for advancing medical science through innovative studies. His contributions to ocular disease research, particularly in understanding the gut-eye axis and corneal wound healing, highlight his interdisciplinary approach. He has authored multiple high-impact journal articles and actively collaborates with global scholars. His research on machine learning applications in medical diagnosis showcases his forward-thinking vision in integrating AI with healthcare. Beyond academia, Wentao Han serves as a reviewer for prestigious journals, contributing to the integrity of scientific publications. His dedication to translational medicine and biomarker identification continues to shape new therapeutic strategies. His work aims to bridge laboratory findings with clinical applications, improving patient outcomes in ophthalmology and metabolic diseases.

Professional Profile 

Orcid

Suitability for the Research for Best Researcher Award – Wentao Han

Wentao Han demonstrates a strong research background in ophthalmology, particularly in the areas of diabetic eye complications, dry eye syndrome, and corneal wound healing. Currently pursuing research at the Second Xiangya Hospital of Central South University, he has made notable contributions to the field, with multiple high-impact publications in reputable journals. His expertise in the “gut metabolites–inflammation–eye axis” and gene therapy for Meibomian Gland Dysfunction (MGD) highlights his innovative approach to addressing critical challenges in ophthalmology.

His publication record is impressive, with multiple papers in Q1 and Q2 journals, including Pharmaceutics, The Ocular Surface, Acta Diabetologica, and Journal of Medical Internet Research. Notably, his work on machine learning prediction models, autophagy in retinal precursor cells, and the gut-eye axis showcases a multidisciplinary research approach. His role as an invited reviewer for respected journals further establishes his credibility in the academic community.

🎓 Education 

Wentao Han is currently pursuing advanced medical research at Central South University, Changsha, China, within the Department of Ophthalmology at the Second Xiangya Hospital. His academic journey reflects a deep commitment to ophthalmic research, focusing on diabetic retinopathy, ocular surface disorders, and corneal healing mechanisms. Through rigorous training and hands-on experience in clinical settings, he has honed his expertise in evidence-based medicine and translational research. His coursework and mentorship under leading ophthalmologists have allowed him to integrate molecular biology with patient-centered investigations. Additionally, he actively participates in research seminars, workshops, and scientific collaborations, reinforcing his knowledge of bioinformatics, gene therapy, and regenerative medicine. His strong foundation in medical sciences, combined with a keen interest in technological advancements, positions him as a promising young researcher in ophthalmology. His education has equipped him with critical skills to contribute to groundbreaking discoveries in the field of ocular diseases.

💼 Professional Experience 

As a researcher in ophthalmology at the Second Xiangya Hospital of Central South University, Wentao Han has contributed significantly to understanding diabetic eye complications and ocular disease mechanisms. His professional experience includes conducting clinical and preclinical studies on dry eye syndrome, corneal wound healing, and the gut-eye axis. He has extensive expertise in meta-analyses, molecular diagnostics, and the application of artificial intelligence in disease prediction. His work in identifying novel biomarkers for diabetic retinopathy has been widely recognized. Additionally, he collaborates with interdisciplinary teams, integrating bioinformatics and evidence-based medicine to develop innovative treatment approaches. Han’s active involvement in academic publishing and peer review for high-impact journals reflects his commitment to advancing medical knowledge. His current projects involve investigating gene therapy for meibomian gland dysfunction and corneal regeneration, with the aim of translating scientific discoveries into clinical applications that enhance patient care in ophthalmology.

🏅 Awards and Recognition 

Wentao Han has received multiple recognitions for his outstanding contributions to ophthalmic research. He has been an invited reviewer for prestigious journals such as Cell Death Discovery (IF = 7) and Acta Diabetologia (IF = 3.9), underscoring his expertise in diabetes-related ocular disorders. His research on gut metabolites’ role in eye diseases has been acknowledged at international conferences. Several of his published articles in Q1 journals have earned high citations, reflecting their impact on the scientific community. Han has also contributed to the development of machine learning prediction models for gestational diabetes mellitus, further showcasing his interdisciplinary proficiency. His involvement in groundbreaking studies on corneal wound healing has positioned him as a promising young researcher in ophthalmology. With a strong publication record, peer recognition, and contributions to medical advancements, Han continues to be a driving force in translational ophthalmic research and clinical innovation.

🌍 Research Skills On Medicine

Wentao Han possesses a diverse set of research skills that bridge molecular biology, clinical medicine, and artificial intelligence applications in ophthalmology. His expertise includes conducting systematic reviews, meta-analyses, and experimental research on diabetic retinopathy and dry eye syndrome. He is proficient in bioinformatics tools for gene analysis and biomarker identification, which he applies to precision medicine. Han is skilled in laboratory techniques such as immunohistochemistry, cell culture, and animal models for ocular disease studies. His ability to integrate AI and machine learning into medical research has led to innovative predictive models for disease diagnosis. Additionally, his work in gene therapy for corneal and meibomian gland dysfunction highlights his translational research capabilities. Han’s interdisciplinary approach allows him to explore novel therapeutic targets, making significant contributions to evidence-based medicine. His research aims to improve diagnostic accuracy and therapeutic interventions in ophthalmic and metabolic disorders.

📖 Publication Top Notes

  • Research Progress and Potential Applications of Spermidine in Ocular Diseases
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Journal of Medical Internet Research, 2022-03-16
    • Year: 2022
    • DOI: 10.2196/26634
  • Genome Analysis and Identification of Key Pathway in Visceral Adipose Tissue from Obesity-Related Diabetes
    • Authors: Wentao Han
    • Citation: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing, 2021-01-22
    • Year: 2021
    • DOI: 10.1145/3448748.3448757
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis (Preprint)
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Preprint, 2020-12-19
    • Year: 2020
    • DOI: 10.2196/preprints.26634
  • Construction of a Knowledge Graph for Diabetes Complications from Expert-Reviewed Clinical Evidences
    • Authors: Wentao Han
    • Citation: Computer Assisted Surgery (Abingdon, England), 2020-11-25
    • Year: 2020
    • DOI: 10.1080/24699322.2020.1850866
    • PMID: 33275462
  • Association Between Retinol Binding Protein 4 and Diabetic Retinopathy Among Type 2 Diabetic Patients: A Meta-analysis
    • Authors: Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang, Huiqun Wu
    • Citation: Acta Diabetologica, 2020-10
    • Year: 2020
    • DOI: 10.1007/s00592-020-01535-3

 

Do Young Kim | Medicine | Best Researcher Award

Posted on by sciencefather

Prof. Do Young Kim | Medicine | Best Researcher Award

Prof. Do Young Kim, Yonsei University College of Medicine South Korea

Do Young Kim is a Professor of Internal Medicine at Yonsei University College of Medicine and a hepatologist at Severance Hospital in Seoul, Korea. Having been part of the faculty since 2007, Dr. Kim is widely recognized for his contributions to hepatology, particularly in hepatocellular carcinoma (HCC). He earned his medical degree from Yonsei University in 1996 and completed his training at Severance Hospital. Dr. Kim’s research experience includes a position as a research associate at Fred Hutchinson Cancer Research Center from 2011 to 2012, where he focused on proteomics and microRNA in HCC.

Professional Profile 

Scopus 

Orcid

Google Scholar

Summary of Suitability for the “Research for Best Researcher Award”

Professor Do Young Kim, a prominent figure in hepatology and internal medicine, has made significant contributions to the field of hepatocellular carcinoma (HCC) and hepatitis C research. As a professor at Yonsei University College of Medicine and a hepatologist at Severance Hospital, he has established himself as a leading expert in his field since 2007. His academic background, including his degree from Yonsei University and specialized training at Severance Hospital, laid a solid foundation for his remarkable career.

His research focus on proteomics and microRNA in HCC, particularly during his tenure at the Fred Hutchinson Cancer Research Center, has led to innovative insights into the mechanisms underlying liver cancer and hepatitis C. This focus has translated into a series of impactful publications, where he has served as the corresponding author in studies that explore new treatment paradigms and diagnostic advancements for HCC. His work on the efficacy and safety of various treatments, including sorafenib and lenvatinib, has become essential reading for clinicians and researchers alike.

🎓 Education 

Dr. Do Young Kim obtained his medical degree from Yonsei University in Seoul, Korea, in 1996. After completing his studies, he underwent medical training at Severance Hospital, where he continued his professional development until 2001. In 2011, Dr. Kim broadened his academic horizons by becoming a research associate at Fred Hutchinson Cancer Research Center, where he focused on proteomics and microRNA in hepatocellular carcinoma (HCC). This international research experience allowed him to deepen his expertise in the molecular aspects of liver cancer. Dr. Kim’s ongoing contributions to medical education and his research have been deeply influenced by his foundational education and global training experiences.

💼 Professional Experience 

Dr. Do Young Kim is currently serving as a Professor of Internal Medicine at Yonsei University College of Medicine and a hepatologist at Severance Hospital in Seoul, Korea. Since joining Severance Hospital in 2007, he has become an integral part of the team, specializing in hepatology and liver diseases. His research has advanced understanding in areas such as hepatocellular carcinoma (HCC) and hepatitis C. In 2011-2012, Dr. Kim expanded his professional expertise by working as a research associate at the Fred Hutchinson Cancer Research Center in Seattle, USA. There, he conducted cutting-edge research in proteomics and microRNA in relation to HCC, which added a new dimension to his medical and scientific career. His ongoing clinical and research contributions have made him a leader in the field of hepatology.

🏅 Awards and Recognition

Dr. Do Young Kim has received significant recognition in the field of hepatology, with several prestigious awards throughout his career. His research on hepatocellular carcinoma (HCC) and hepatitis C has earned him acknowledgment both nationally and internationally. He is particularly recognized for his contributions to clinical practices surrounding HCC and his extensive publication record in highly respected medical journals. His role as a corresponding author in key studies, such as those published in Hepatology and J Gastroenterol Hepatol, highlights his leadership in advancing knowledge about liver disease. Dr. Kim’s research and clinical expertise have earned him the trust and respect of colleagues in the medical community, solidifying his position as a leading expert in the field of internal medicine and hepatology.

🌍 Research Skills On Medicine

Dr. Do Young Kim’s research skills are highly regarded, particularly in the fields of hepatocellular carcinoma (HCC) and hepatitis C. He specializes in proteomics and microRNA, utilizing these molecular techniques to gain deeper insights into the pathophysiology of liver diseases. His time at the Fred Hutchinson Cancer Research Center honed his skills in advanced research methodologies, which he continues to apply in his work at Severance Hospital and Yonsei University College of Medicine. Dr. Kim’s research is both experimental and clinical, bridging the gap between laboratory findings and real-world medical applications. He is skilled in conducting large-scale studies, analyzing complex data, and collaborating with multidisciplinary teams to advance scientific understanding. His research has led to significant clinical improvements in the management of liver diseases, particularly in HCC treatment and early detection.

📖 Publication Top Notes

  • Letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
    • Authors: Chon, Y.E., Kim, D.Y., Chon, H.J., Kim, D.Y.
    • Citation: Clinical and Molecular Hepatology, 2025, 31(1), pp. e98–e100
  • The Possible Impact of Zinc-Enriched Multivitamins on Treatment-Naïve Recurrent Aphthous Stomatitis Patients
    • Authors: Seo, H.R., Chung, K.B., Kim, D.-Y.
    • Citation: Journal of Clinical Medicine, 2025, 14(1), 260
  • Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
    • Authors: Kim, J.E., Lee, S., Kang, H., Lee, Y.W., Kim, M.-B.
    • Citation: Annals of Dermatology, 2024, 36(6), pp. 376–383
  • Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
    • Authors: Kim, K.-P., Kim, K.M., Ryoo, B.-Y., Kim, J.-A., Kim, K.-H.
    • Citation: Liver Cancer, 2024, 13(6), pp. 610–628
  • Detection of NUDT15 R139C Variants and Azathioprine Utilization in Patients with Dermatologic Conditions
    • Authors: Chung, K.B., Sung, H., Kim, D.-Y.
    • Citation: International Journal of Dermatology, 2024, 63(3), pp. e75–e77
  • Quantitative Analysis of Hair Luster in a Novel Ultraviolet-Irradiated Mouse Model
    • Authors: Chung, K.B., Lee, Y.I., Kim, Y.J., Kim, D.-Y., Lee, J.H.
    • Citation: International Journal of Molecular Sciences, 2024, 25(3), 1885
    • Citations: 1
  • Heterogeneity in Keloid Scars: Influence of Mechanical Stretching on Keloids Arising from Different Anatomical Sites
    • Authors: Lee, Y.I., Yang, Y., Ham, S., Kim, D.-Y., Lee, J.H.
    • Citation: Journal of Investigative Dermatology, 2024
  • The Efficacy of Treatment for Hepatocellular Carcinoma in Elderly Patients
    • Authors: Lee, H.A., Lee, S., Lee, H.L., Rhim, H., Kim, D.Y.
    • Citation: Journal of Liver Cancer, 2023, 23(2), pp. 362–376
    • Citations: 2
  • Predictive Biomarkers of Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Treatment
    • Authors: Chon, Y.E., Cheon, J., Kim, H., Chon, H.J., Kim, B.K.
    • Citation: Cancer Medicine, 2023, 12(3), pp. 2731–2738
    • Citations: 26
  • Activated TAZ Induces Liver Cancer in Collaboration with EGFR/HER2 Signaling Pathways
    • Authors: Moon, H., Park, H., Chae, M.J., Kim, D.Y., Ro, S.W.
    • Citation: BMC Cancer, 2022, 22(1), 423
    • Citations: 11

Sarah Depallens | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Sarah Depallens | Medicine | Best Researcher Award

👤 Dr. Sarah Depallens, CAN team Lausanne CHUV, Switzerland

Dr. Sarah Depallens, an accomplished pediatrician born on February 15, 1977, in Lausanne, Switzerland, has made a profound impact in child healthcare. Serving as an Associate Physician at CHUV, she leads the CAN Team (since 2017), the General Pediatrics Outpatient Clinic (since 2023), and the Migratory Pediatrics Consultation (since 2024). Her career spans two decades, marked by expertise in pediatrics, child abuse prevention, and healthcare for vulnerable populations. Dr. Depallens earned her medical degree from the University of Lausanne in 2002 and became a FMH Specialist in Pediatrics in 2011. Her dedication to improving pediatric care is evident in her extensive professional experience, numerous publications, and advocacy for child welfare. Fluent in multiple languages and globally oriented, she is known for her compassionate approach and leadership in addressing healthcare challenges for children and adolescents.

Professional Profile

Orcid

🌟  Suitability for the Research for Best Researcher Award: Dr. Sarah Depallens

Dr. Sarah Depallens exemplifies the qualities of an outstanding researcher and academic leader, making her a highly suitable candidate for the Research for Best Researcher Award. Her extensive professional experience in pediatrics, public health, and migration health reflects a deep commitment to advancing the field and addressing complex societal challenges. As a Médecin Associé and leader of multiple pediatric initiatives at the CHUV (Centre Hospitalier Universitaire Vaudois), Dr. Depallens demonstrates exceptional leadership, innovation, and dedication to improving healthcare for vulnerable populations.

Research Contributions and Professional Impact : Dr. Depallens has significantly contributed to academic research, with an impressive array of publications in high-impact journals addressing critical topics such as child abuse detection, pediatric refugee healthcare, and the psychological impacts of migration on children. Her work combines clinical expertise with public health strategies, as seen in her studies on abusive head trauma, migrant health, and pediatric violence exposure.

🎓 Education 

Dr. Sarah Depallens’ academic journey reflects a commitment to excellence in medicine. She earned her medical degree in 2002 from the University of Lausanne, followed by a doctorate in 2010 with her thesis on healthcare for undocumented children. Dr. Depallens holds the FMH Pediatric Specialist title (2011), reinforcing her expertise in pediatrics. Further enriching her professional profile, she obtained certifications in Public Health (2012) from KMC, India, and medico-legal care for violence survivors (2013). Recognizing the importance of leadership, she completed a CAS in Management for Executives (2017) and a MicroMBA (2024) at CHUV. Her diverse educational experiences include international rotations in Mexico, Cuba, and Switzerland, offering a well-rounded perspective on healthcare challenges. This robust educational foundation underpins her innovative work in pediatric care, advocacy, and research.

💼  Professional Experience 

Dr. Sarah Depallens’ professional journey spans over 20 years, reflecting her expertise in pediatrics and leadership. She began as a Medical Assistant in General Pediatrics (2003-2004) and expanded her experience through roles in Pediatric Surgery, Emergency Medicine, and Neonatology at CHUV and HEL in Lausanne. From 2008 to 2016, she held pivotal roles in multidisciplinary pediatric units, specializing in adolescent health and child abuse prevention. Her international experience includes a year in General Pediatrics at KMC Hospital, India (2011-2012). Since 2017, Dr. Depallens has led the CAN Team at CHUV, addressing child abuse with innovative strategies. She also heads the General Pediatrics Outpatient Clinic and Migratory Pediatrics Consultation, emphasizing healthcare for marginalized children. Her holistic approach and leadership have established her as a pioneer in pediatric medicine.

🏅 Awards and Recognitions

Dr. Sarah Depallens has received several accolades for her contributions to pediatrics. Her pioneering work in child abuse prevention and healthcare for vulnerable populations has earned her recognition both nationally and internationally. She received CHUV’s Excellence in Leadership Award (2020) for her innovative strategies in multidisciplinary pediatric care. Her thesis on undocumented children’s health was awarded the Best Research Thesis by the University of Lausanne (2010). Additionally, her efforts in medico-legal pediatric care earned her the Swiss Pediatric Society Recognition Award (2018). Dr. Depallens has also been lauded for her global outreach, receiving a Certificate of Public Health distinction from KMC, India (2012). Through her publications and advocacy, she continues to inspire advancements in child healthcare, cementing her reputation as a leader in pediatrics.

🌍 Research Skills On Medicine 

Dr. Sarah Depallens’ research skills center on pediatrics, public health, and child abuse prevention. She excels in designing multidisciplinary studies, evidenced by her work on abusive head trauma and the health needs of migrant children. Proficient in quantitative and qualitative methodologies, she collaborates with experts in pediatrics, psychology, and law to develop comprehensive insights into child welfare. Dr. Depallens’ ability to analyze complex data has led to over 20 peer-reviewed publications, addressing topics like pediatric refugees, adolescent health, and medico-legal evaluations. Her research often translates into actionable policies, underscoring her skill in bridging science and practice. Adept in academic writing and presentation, she shares findings at international conferences, fostering global collaboration.

📖 Publication Top Notes

  • Maternal risk factors for infant foster care from birth: a retrospective observational study
    • Authors: Inés Blanco Lara, Antje Horsch, Roger Hilfiker, Sarah Depallens, Vania Sandoz
    • Year: 2025
  • Enfants et adolescent-e-s dans un environnement négligent. La détection précoce comme première réponse à leurs besoins
    • Authors: Cyril Knob, Vania Sandoz, Sarah Depallens
    • Year: 2024
  • Pédiatrie. Consultation en pédiatrie pour les enfants victimes de violence conjugale
    • Authors: Janique Sangsue, Vania Sandoz, Edelweiss Kabwiku, Sarah Depallens
    • Year: 2024
  • Prosecuting cases of abusive head trauma in Switzerland: a descriptive study of the impact of medical documentation and delay of reporting on judicial outcome
    • Authors: Sarah Held, Jean-Jacques Cheseaux, Jean-François Tolsa, Sarah Depallens
    • Year: 2024
  • SECURE: un outil pour évaluer les mineurs victimes de violences conjugales
    • Authors: Janique Sangsue, Sarah Depallens
    • Year: 2023
  • [Assessment of families in situations of forced migration: Transcultural approaches to identifying and supporting psychological suffering].
    • Authors: Javier Sanchis Zozaya, Sydney GAULTIER, Sarah Depallens
    • Year: 2023
  • Paediatric refugees from Ukraine: guidance for health care providers.
    • Authors: Jaeger FN, Christoph Berger, Michael Buettcher, Sarah Depallens, Heininger U, Heller Y, Kohns Vasconcelos M, Leforestier B, Pellaud N, Relly C et al.
    • Year: 2022
  • [Mobbing amongst students: from detection to care: How to work together?]
    • Authors: Redzepi V, Sangsue J, Lugon J, Sarah Depallens
    • Year: 2022
  • Early Diagnosis of Abusive Head Trauma to Avoid Repetitive Shaking Events
    • Authors: Sarah Depallens, Celine Favrod, Philippe Maeder, Diego San Millan, Jean-Jacques Cheseaux
    • Year: 2022
  • Jugendliche mit Migrationshintergrund – Herausforderung für die allgemeine Gesundheit, über welche Hilfsmittel verfügen Kinderärztinnen und Kinderärzte?
    • Authors: Sarah Depallens, Caroline Heiniger, Karine Tzaud
    • Year: 2021

FANCY GAETE | Medicine | Women Researcher Award

Posted on by sciencefather

Dr. FANCY GAETE | Medicine | Women Researcher Award

👤 Dr. FANCY GAETE, HOSPITAL SANTIAGO ORIENTE DR. LUIS TISNÉ BROUSSE, Chile

Dr. Fancy Gaete Verdejo is a renowned anatomopathologist with 26 years of experience in Chile’s public healthcare system. As a pioneer in breast cancer diagnostics, she established the national reference center for the in situ hybridization technique for HER2 testing, which has been operational since 2011. In 2022, she transitioned from the manual FISH HER2 technique to the automated DISH HER2 method, integrating digital pathology and AI algorithms. This innovation led to a 13.02% reduction in costs, an 83.86% improvement in response time, and an 11.29% increase in productivity. Dr. Gaete is actively involved in the advancement of pathology practices and plays a leadership role as the President of the Chilean Society of Pathological Anatomy and the Chilean Society of Mastology.

Professional Profile

Scopus

🌟  Assessment of Suitability for the Research for Women Researcher Award

Summary of Suitability
Dr. Fancy Gaete Verdejo exemplifies an exceptional commitment to advancing research and innovation in pathology, specifically breast cancer diagnostics, within the Chilean public health system. Her pioneering efforts to centralize the HER2 in situ hybridization technique have significantly impacted breast cancer pathology in Chile. By introducing the automated DISH HER2 technique integrated with digital pathology and artificial intelligence (AI) algorithms, she has revolutionized diagnostic efficiency, reducing costs by 13.02%, cutting response times by 83.86%, and improving productivity by 11.29%.

Dr. Verdejo’s leadership in developing a national reference center for HER2 analysis has not only elevated the quality of public healthcare but also fostered a data-driven approach to diagnostics. Her dedication to reducing healthcare disparities through affordable and accessible diagnostic innovations underscores her suitability for this award. Moreover, her current roles as President of the Chilean Society of Pathological Anatomy and the Chilean Society of Mastology further highlight her influence and commitment to the field.

🎓  Education

Dr. Gaete completed her medical studies at the University of Chile, where she specialized in Anatomopathology. Her passion for advancing medical diagnostics led her to focus on molecular pathology, particularly in breast cancer. She further honed her skills by obtaining advanced training in digital pathology and artificial intelligence (AI) techniques, ensuring she stayed at the forefront of technological innovations in the field. Throughout her career, Dr. Gaete has pursued continuous education, contributing significantly to the implementation of cutting-edge technologies in public health systems. Her work has not only reshaped breast cancer diagnostic processes but has also inspired others in the field to incorporate AI and digital tools to improve healthcare outcomes.

💼  Professional Experience 

Dr. Fancy Gaete Verdejo has dedicated over 26 years of service in the Chilean public healthcare system. As an anatomopathologist, she has specialized in the diagnosis of breast cancer, implementing groundbreaking techniques and driving efficiency in pathology labs. In 2011, she established the national reference center for HER2 in situ hybridization in breast cancer, advancing diagnostic capabilities. Dr. Gaete’s work became more impactful in 2022 when she led the transition from manual FISH HER2 testing to an automated DISH HER2 method, integrating digital pathology with AI algorithms. This transition dramatically improved the turnaround time, reduced costs, and enhanced productivity within the system. Beyond her technical expertise, Dr. Gaete holds leadership roles in major Chilean medical societies, such as the Chilean Society of Pathological Anatomy and the Chilean Society of Mastology, where she contributes to the shaping of national health policies.

🏅  Awards and Recognition

Dr. Gaete’s pioneering contributions have earned her numerous accolades throughout her distinguished career. She has been recognized for her role in advancing breast cancer diagnostics in Chile, particularly through her development of the national reference center for HER2 in situ hybridization. Her innovative work in integrating digital pathology with AI has also been widely acknowledged for improving diagnostic accuracy and system efficiency. Additionally, Dr. Gaete’s leadership in the Chilean Society of Pathological Anatomy (President 2023-2026) and the Chilean Society of Mastology (President 2024-2026) reflects the esteem in which she is held by her peers. These positions have enabled her to influence national healthcare policies and standards in pathology and oncology. Her work has also led to several collaborations with international institutions, further expanding her impact on the global healthcare community.

🌍  Research Skills On Medicine

Dr. Gaete is an expert in anatomical pathology with a deep focus on molecular and digital pathology, particularly in breast cancer. Her research skills include a solid understanding of diagnostic techniques, data analysis, and the integration of innovative technologies such as artificial intelligence (AI) and digital imaging into pathology workflows. She excels in evaluating the economic impact of medical technologies, particularly in healthcare systems. Her research has significantly influenced the adoption of digital pathology and AI in Chile, demonstrating how these tools can optimize diagnostic precision and efficiency. Furthermore, Dr. Gaete is highly skilled in research management, leading both academic and industry collaborations. Her work has contributed to the publication of influential studies on the cost-effectiveness of healthcare technologies, such as her ongoing research on the economic impact of integrative digital pathology in public breast cancer diagnostics.

📖 Publication Top Notes

  • Impact of the Chilean explicit guarantees health system (GES) on breast cancer treatment | Resultados del tratamiento del cáncer de mama, programa nacional de cáncer del adulto
    • Authors: Castillo, C.S.M., Cabrera, M.E.C., Derio P., L., Gaete V., F., Cavada CH., G.
    • Journal: Revista Medica de Chile
    • Year: 2017
    • Volume: 145(12)
    • Pages: 1507–1513
    • Citations: 14
  • Spontaneous quadruplet pregnancy. A challenge for the multidisciplinary team in a health service | Gestación cuádruple espontánea. Un desafío para el equipo multidisciplinario en un servicio de salud
    • Authors: Salgado M., E., Lattus O., J., Barrera C., V., Fritis L., A., Gaete V., F.
    • Journal: Revista Chilena de Obstetricia y Ginecologia
    • Year: 2006
    • Volume: 71(1)
    • Pages: 35–42
    • Citations: 1
  • Jejunal diverticulosis as cause of gastrointestinal hemorrhages. Case report | Diverticulosis yeyunal: Una causa infrecuente de hemorragia digestiva. Caso clínico
    • Authors: Zapata L., R., Rojas S., C., Gaete V., F.
    • Journal: Revista Medica de Chile
    • Year: 2000
    • Volume: 128(10)
    • Pages: 1133–1138
    • Citations: 4